export const sampleAiResponses = [
  "ğŸ¯ **ABC Segmentation - Critical Medicines**: Class A items (Lipitor RX1287, Metformin RX3456, Insulin RX6734) represent 68.5% of revenue (â‚¹52.8M) but show 12% forecast variance in Delhi and Mumbai hospitals. Recommend daily inventory reviews and dynamic safety stock buffers (+22% for Q1 2025) to prevent stockouts of life-saving medications worth â‚¹2.4M.",
  "ğŸ“ˆ **Seasonal Disease Pattern Intelligence**: Epidemiological data shows 42% surge in respiratory medication demand during winter months (Nov-Feb) and 38% spike in antihistamines during pollen season (Mar-Apr). Historical data shows Crocin (OTC2145) and Azithromycin (RX7845) lead demand. Action: Pre-position inventory 4 weeks ahead in top metro hospitals and retail pharmacies.",
  "ğŸŒ **Channel Performance - E-Pharmacy Growth**: E-pharmacy channel growing at 35% CAGR vs 6% for traditional retail pharmacies. Chronic disease medications (Lipitor RX1287, Metformin RX3456) show 82% e-pharmacy preference in Bengaluru and Pune markets. Reallocate 30% inventory to online fulfillment centers to capture â‚¹4.8M incremental revenue.",
  "âš•ï¸ **Patent Expiry Alert - Atorvastatin**: Patent expiration for Atorvastatin (Lipitor RX1287) in Q2 2025 will trigger 55-70% volume surge as generics flood market. Price erosion expected at 40-50%. Secure API supply commitments now, increase manufacturing capacity by 60%, and build 8 weeks safety stock to capture â‚¹6.2M market opportunity before competition intensifies.",
  "ğŸ¥ **Hospital vs Retail Pharmacy Dynamics**: Large hospital chains (Apollo, Fortis, Max) show 22% better forecast accuracy due to EHR-integrated ordering patterns. Small independent pharmacies exhibit 38% higher demand volatility. Deploy institution-specific forecasting models and offer vendor-managed inventory (VMI) programs to improve MAPE by 3.8 points and reduce stockouts by 28%.",
  "ğŸ“Š **Cold Chain Compliance - Temperature-Sensitive Drugs**: XYZ segmentation identifies 45 high-variability SKUs requiring enhanced cold chain monitoring. Insulin (RX6734) and biologics show 32% spoilage risk during monsoon season (Jun-Sep) in coastal regions. Invest in IoT-enabled temperature monitoring, increase cold storage capacity by 25%, and implement real-time alert systems.",
  "ğŸ’Š **Chronic vs Acute Medication Planning**: Chronic disease medications (diabetes, hypertension, cholesterol) show predictable 8-12 week refill cycles with 94% adherence. Acute care drugs exhibit 250% demand volatility. Implement subscription-based auto-refill programs for chronic meds to lock in â‚¹18M recurring revenue and free up working capital by â‚¹3.2M.",
  "ğŸš¨ **Regulatory Compliance - CDSCO Updates**: New CDSCO track-and-trace requirements (effective Jan 2025) mandate serialization for all Schedule H drugs. Implementation will cause 3-4 week supply disruption for 28% of prescription SKUs. Build 10 weeks safety stock for RX-category products, upgrade packaging lines, and coordinate with hospital procurement teams on transition.",
  "ğŸ’° **Promotional Strategy - Seasonal Health Camps**: Last 8 health camp tie-ups generated â‚¹68K average spend with 4.2x ROI (22% demand lift for preventive care products). However, chronic medication promotions show diminishing returns below 3.1x ROI. Optimize campaigns: Partner with diagnostic labs, focus on tier-2 cities (Jaipur, Chandigarh, Lucknow), and bundle vitamin/supplement portfolios.",
  "ğŸ”„ **API Supply Chain Optimization**: Active pharmaceutical ingredient (API) analysis reveals China-sourced materials have 28-35 day lead times with high variability (Â±8 days). Diversifying to Indian API manufacturers (Aurobindo, Divi's) reduces lead time to 18-22 days. Strategic shift could reduce pipeline inventory by â‚¹12M, improve supply resilience by 45%, and support 'Make in India' initiatives."
];